MedTrace Logo

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems

NCT00715884 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 678

Last updated 2014-01-20

Study results available
· View outcomes & findings →

Summary

The objective of this study is to show similar (non-inferior) safety and effectiveness between CYPHER® ELITE™ and CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems in a prospective, multi-center, randomized clinical study for the treatment of de novo native coronary lesions.

Conditions

Interventions

DEVICE

CYPHER® ELITE™ Sirolimus-Eluting Stent System

Drug eluting stent

DEVICE

CYPHER® Bx VELOCITY® Sirolimus-eluting Stent System

Drug eluting stent

Sponsors & Collaborators

  • Cordis Corporation

    lead INDUSTRY

Principal Investigators

  • Lowell Satler, MD · Medstar Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-03-31
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715884 on ClinicalTrials.gov